CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms
Margarida Ruas1, Fiona Gregory, Rebecca Jones
1Cancer Research UK, London Research Institute, 44 Lincoln's Inn Fields, London, UK.
Abstract:
Replicative senescence of human diploid fibroblasts (HDFs) is largely implemented by the cyclin-dependent kinase (CDK) inhibitors p16(INK4a) and p21(CIP1). Their accumulation results in a loss of CDK2 activity, and cells arrest with the retinoblastoma protein (pRb) in its hypophosphorylated state. It has become standard practice to bypass the effects of p16(INK4a) by overexpressing CDK4 or a variant form that is unable to bind to INK4 proteins. Although CDK4 and CDK6 and their INK4-insensitive variants can extend the life span of HDFs, they also cause a substantial increase in the levels of endogenous p16(INK4a). Here we show that CDK4 and CDK6 can extend the life span of HDFs that have inactivating mutations in both alleles of INK4a or in which INK4a levels are repressed, indicating that overexpression of CDK4/6 is not equivalent to ablation of p16(INK4a). However, catalytically inactive versions of these kinases are unable to extend the replicative life span, suggesting that the impact of ectopic CDK4/6 depends on their ability to phosphorylate as yet unidentified substrates rather than to sequester CDK inhibitors. Since p16(INK4a) deficiency, CDK4 expression, and p53 or p21(CIP1) ablation have additive effects on replicative life span, our results underscore the idea that senescence is an integrated response to diverse signals.
Insights
Cyclin-dependent kinase (CDK) inhibitors like p16INK4a and p21CIP1 drive cellular senescence. Overexpressing CDK4/6 extends fibroblast lifespan, but only when p16INK4a is absent, suggesting novel substrate phosphorylation is key.
Area of Science:
- Cell Biology
- Molecular Biology
- Aging Research
Background:
- Replicative senescence in human diploid fibroblasts (HDFs) is primarily mediated by CDK inhibitors p16INK4a and p21CIP1.
- These inhibitors lead to cell cycle arrest by inhibiting CDK2 activity and hypophosphorylating the retinoblastoma protein (pRb).
Purpose of the Study:
- To investigate the role of CDK4 and CDK6 in extending HDF lifespan, particularly in relation to p16INK4a.
- To determine if CDK4/6 overexpression is equivalent to p16INK4a ablation.
- To elucidate the mechanism by which ectopic CDK4/6 impacts HDF replicative lifespan.
Main Methods:
- Overexpression of CDK4 or CDK6, including INK4-insensitive variants, in HDFs.
- Analysis of HDFs with inactivating mutations in INK4a alleles or repressed INK4a levels.
- Utilizing catalytically inactive versions of CDK4/6 to assess kinase activity dependence.
- Examining the additive effects of p16INK4a deficiency, CDK4 expression, and p53/p21CIP1 ablation.
Main Results:
- Overexpression of CDK4 and CDK6 extends HDF lifespan, but this effect is contingent on the absence or repression of p16INK4a.
- Catalytically inactive CDK4/6 variants failed to extend replicative lifespan, indicating phosphorylation of unknown substrates is crucial.
- Combined genetic alterations (p16INK4a deficiency, CDK4 expression, p53/p21CIP1 ablation) showed additive effects on lifespan extension.
Conclusions:
- Overexpression of CDK4/6 is not equivalent to p16INK4a ablation in extending HDF lifespan.
- The lifespan-extending impact of ectopic CDK4/6 relies on their kinase activity, likely through phosphorylation of novel substrates, not solely inhibitor sequestration.
- Cellular senescence is a complex, integrated response to various signaling pathways.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

